Advertisement
UK markets open in 1 hour 55 minutes

  • NIKKEI 225

    38,365.82
    -866.98 (-2.21%)
     

  • HANG SENG

    16,279.56
    -320.90 (-1.93%)
     

  • CRUDE OIL

    85.88
    +0.47 (+0.55%)
     

  • GOLD FUTURES

    2,402.10
    +19.10 (+0.80%)
     

  • DOW

    37,735.11
    -248.13 (-0.65%)
     

  • Bitcoin GBP

    50,219.44
    -2,112.10 (-4.04%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,885.02
    -290.08 (-1.79%)
     

  • UK FTSE All Share

    4,338.90
    -14.76 (-0.34%)
     
Stocks:

Trending tickers: Oil, Goldman Sachs, Bitcoin and Ethereum

The latest investor updates on stocks that are trending on Monday

ChromaDex (CDXC): Moving Average Crossover Alert

Zacks Equity Research
Updated
Crown Castle (CCI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ChromaDex Corporation CDXC could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for CDXC broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.

This has already started to take place, as the stock has moved lower by 10.1% in the past four weeks. And with the recent moving average crossover, investors have to think that more unfavorable trading is ahead for CDXC stock.

If that wasn’t enough, ChromaDex isn’t looking too great from an earnings estimate revision perspective either. It appears as though many analysts have been reducing their earnings expectations for the stock lately, which is usually not a good sign of things to come.

Consider that in the last 30 days, 1 estimate have been reduced, while none has moved higher. Add this in to a similar move lower in the consensus estimate, and there is plenty of reason to be bearish here.

ADVERTISEMENT

That is why we currently have a Zacks Rank #5 (Strong Sell) on this stock and are looking for it to underperform in the weeks ahead. So either avoid this stock or consider jumping ship until the estimates and technical factors turn around for CDXC. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ChromaDex Corporation (CDXC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.